DPIIT recognised startup Government of India
Startup India
Avieum Life Sciences Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2019
₹2.74 Cr
▲ 545% YoY
Net loss · FY 2019
₹3.42 Cr
Net margin -124.9%
EBITDA · FY 2019
-₹2.8 Cr
EBITDA margin -102.3%
Authorised capital
₹4 Lakh
Registered with MCA
Paid-up capital
₹3.25 Lakh
Issued & subscribed
Open charges
₹2.75 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
49
Provident fund records
About Avieum Life Sciences Private Limited
Data last updated:
Avieum Life Sciences Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 11 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U73100PN2017PTC167898. Its GSTIN is 27AAPCA1457R1ZX (Maharashtra).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹3.25 Lakh. It is led by directors including Ramesh Ratan Kale and Vanita Ramesh Kale.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at International Biotech Park Genesis Square Gr Flr MIDC Hinjewadi Phase II Village Mann, Pune, Maharashtra, India – 411057.
As per the financials filed for FY 2019, the company reported a revenue of ₹2.74 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.42 Cr (net margin -124.9%) and EBITDA of -₹2.8 Cr (EBITDA margin -102.3%).
The company has about 49 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Avieum Life Sciences. As per MCA filings, the company has open charges of ₹2.75 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 1 case is pending. The company has 8 deals on record (5 funding rounds, 3 rights issues), with disclosed funding of ₹6.44 Cr; the latest was in March 2020.
Avieum Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0074852). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avieum.com.
Company details
CIN U73100PN2017PTC167898
Registration Number 167898
Incorporation Date 11 January 2017
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-MH-26-0074852
Recognitions & Rankings of Avieum Life Sciences
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2021-22)
- Udyam number
- UDYAM-MH-26-0074852
Contact details
Avieum Life Sciences Private Limited's registered office is in Pune, Maharashtra. Its website is avieum.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressInternational Biotech Park Genesis Square Gr Flr MIDC Hinjewadi Phase II Village Mann, Pune, Maharashtra, India – 411057
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Avieum Life Sciences Private Limited, buy the company report.
Comprehensive company report
Avieum Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Avieum Life Sciences operates one associated brand: Avieum Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides synthetic and medicinal chemistry, FBDD, and process development services for drug development. | avieum.com |
Business activity
The main business activity of Avieum Life Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Avieum Life Sciences Private Limited, buy the company report.
Financials of Avieum Life Sciences Private Limited
FY 2019 filings availableAvieum Life Sciences Private Limited reported revenue of ₹2.74 Cr (up 545% YoY) for FY 2019.
Revenue · FY 2019
₹2.74 Cr ▲ 545%
Net loss · FY 2019
₹3.42 Cr margin -124.9%
EBITDA · FY 2019
-₹2.8 Cr margin -102.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 545%
EBITDA CAGR growth
1 year
▼ 19%
Revenue rose 545% in the latest year. EBITDA fell 19% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹2.74 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.8 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.42 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -102.3% | ||
| Net Profit Margin | -124.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Avieum Life Sciences Private Limited, buy the company report.
Board of directors of Avieum Life Sciences Private Limited
Avieum Life Sciences has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Ratan Kale | Director | 11 Jan 2017 | 9 Years 9 Months | Current |
| Vanita Ramesh Kale | Director | 11 Jan 2017 | 9 Years 9 Months | Current |
| Sanjay Iresh Chandake | Director | 20 Jan 2018 | 8 Years 9 Months | Current |
| Ravindra Devram Wakchaure | Director | 26 Dec 2019 | 6 Years 10 Months | Current |
Auditor
Avieum Life Sciences Private Limited is audited by BAHETI & SOMANI LLP for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BAHETI & SOMANI LLP | FY 2019 | 124298W |
Shareholding
The shareholding of Avieum Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Avieum Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Nov 2017 | 100142021 | Bank of India | ₹2.75 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Avieum Life Sciences Private Limited has 8 deals on record (5 funding rounds, 3 rights issues), with disclosed funding of ₹6.44 Cr; the latest was in March 2020.
Total deals
8
Funding rounds
5
Rights issues
3
Disclosed funding
₹6.44 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Funding round | ₹3.34 Cr | Investors: 2 individuals |
| Jul 2019 | Funding round | ₹1.17 Cr | Investors: an individual |
| Sep 2018 | Rights issue | ₹3.09 Cr | Investors: 4 individuals |
| Apr 2018 | Rights issue | ₹52.2 Lakh | Investors: 3 individuals |
| Mar 2018 | Funding round | ₹67.5 Lakh | Investors: 2 individuals |
To see the full deal history of Avieum Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Avieum Life Sciences Private Limited has 5 court cases on record: 5 filed against it. 1 case is pending and 4 are disposed.
Total cases
5
Filed against the company
5
Pending
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 1 |
Cases on record (3 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Cheque dishonour complaint | Filed against the company by Ymc India Private Limited | Pending |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by International Biotech Park Ltd. Through Ramesh Shinde | Disposed |
| District court, Ahmednagar, Maharashtra | Criminal miscellaneous application | Filed against the company by Bank of India | Disposed |
To see the full case history of Avieum Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avieum Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Avieum Life Sciences Private Limited has a workforce of 49 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
49
Active EPFO establishments
1
Employee growth
6.52%
GST
Avieum Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA1457R1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avieum Life Sciences Private Limited, buy the company report.
Recent activity
Avieum Life Sciences Private Limited has 7 board changes on record since 2017: 4 appointments and 3 cessations. The latest: Prerana Sambhaji Patil ceased to be Director on 01 Sep 2021.
Ceased
Prerana Sambhaji Patil ceased to be Director.
Ceased
Vikram Khanderao Chede ceased to be Director.
Appointed
Ravindra Devram Wakchaure was appointed as Director.
AGM
Avieum Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Filing
Avieum Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Pune.
Ceased
Sanjay Iresh Chandake ceased to be Additional Director.
Appointed
Sanjay Iresh Chandake was appointed as Director.
Charges
A charge with Bank Of India amounted to Rs. 275.00 Lakh with Charge ID 100142021 was registered on 29 Nov 2017.
Appointed
Ramesh Ratan Kale was appointed as Director.
Appointed
Vanita Ramesh Kale was appointed as Director.
Incorporation
11 Jan 2017
Avieum Life Sciences Private Limited was registered on 11 Jan 2017 with Roc Pune & aged 9 years 9 months as per MCA records.
Frequently asked questions
Avieum Life Sciences is an active private limited company based in Pune, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 11 January 2017 (9+ years old) and is registered under CIN U73100PN2017PTC167898.
Avieum Life Sciences has 4 current directors:
- Ramesh Ratan Kale - Director
- Vanita Ramesh Kale - Director
- Sanjay Iresh Chandake - Director
- Ravindra Devram Wakchaure - Director
The latest financial statements of Avieum Life Sciences on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Avieum Life Sciences is 27AAPCA1457R1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Avieum Life Sciences is U73100PN2017PTC167898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avieum Life Sciences has 5 court cases on record: 5 filed against it. 1 is pending.
Avieum Life Sciences was incorporated on 11 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Avieum Life Sciences has 8 deals on record (5 funding rounds, 3 rights issues), with disclosed funding of ₹6.44 Cr; the latest was in March 2020.
Prerana Sambhaji Patil ceased to be Director on 01 Sep 2021. Vikram Khanderao Chede ceased to be Director on 06 Jul 2021. Ravindra Devram Wakchaure was appointed as Director on 26 Dec 2019. Avieum Life Sciences has 7 board changes on record in total.
Yes, Avieum Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages